Sepsis is a potentially fatal syndrome mediated by an early [eg, tumor necrosis factor-alpha (TNF-α)] and late [high-mobility group box 1 (HMGB-1)] cytokine response to infection. Sepsis-induced acute kidney injury (ARI) is associated with high mortality.

C-Fos / activator protein-1 (AP-1) controls the transactivation of pro-inflammatory cytokines through the binding of AP-1 in the promoter region. T-5224 is a de novo small molecule c-Fos / AP-1 inhibitor that controls the gene expression of multiple pro-inflammatory cytokines. We investigated whether T-5224, a selective c-Fos / AP-1 inhibitor, improves survival in lethal lipopolysaccharide (LPS) -induced AKI by inhibiting early (TNF-α) and late (HMGB-) pro-inflammatory cytokine responses. 1).


The mice were divided into four groups (control, LPS, LPS + T-5224, and T-5224 only). Control mice were administered a polyvinylpyrrolidone (PVP) solution orally, immediately after intraperitoneal (i.p.) injection of saline. LPS mice were administered a PVP solution orally immediately after i.p. Injection of LPS (10 mg/kg). LPS + T-5224 mice were administered T-5224 orally (300 mg / kg) immediately after i.p. LPS injection.

T-5224 mice were administered T-5224 orally (300 mg/kg) after i.p. saline injection. Serum concentrations of TNF-α, HMBG-1, and interleukin (IL) -10 were measured by an enzyme-linked immunosorbent assay (ELISA). Serum blood urea nitrogen (BUN) and creatinine concentrations were commercially analyzed. Finally, a histological examination of the kidney was performed.


Treatment with T-5224 decreased serum levels of TNF-α and HMGB-1 and increased survival after LPS injection. In addition, treatment with T-5224 decreased serum BUN and creatinine levels, but increased serum IL-10 levels. LPS-induced pathological changes in the kidney were attenuated by treatment with T-5224.


These results suggest that T-5224, a selective c-Fos / AP-1 inhibitor, inhibits the expression of early and late pro-inflammatory cytokines, protecting mice from LPS-induced lethality. T-5224 is a potential approach to decrease lethality in sepsis-induced ARF.


T-5224, C-Fos / activator protein-1, Lipopolysaccharide (LPS), Tumor necrosis factor-alpha (TNF-α), Interleukin-10 (IL-10), High mobility group chart-1 (HMGB-1)

Leave a Reply

Your email address will not be published. Required fields are marked *

Blog PCR

Human monkeypox – After 40 years, an unintended consequence of smallpox eradication

Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation of routine smallpox vaccination in most countries. It is estimated that over 70% of the world’s population is no longer protected against smallpox, and through cross-immunity, to closely related orthopox viruses such as monkeypox. Monkeypox is now a re-emerging disease. […]

Read More
Blog parg antibody

A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo

Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo, where MPX is endemic, has uncovered multiple cases of MPX and varicella zoster virus (VZV) coinfections. The purpose of this study was to verify if coinfections occur and to characterize the clinical nature of these cases. Clinical, epidemiological, and laboratory results were used to […]

Read More